Commercial-stage biopharmaceutical company TG Therapeutics and Samsung Biologics are expanding a large-scale manufacturing contract for the former’s ublituximab, an investigational monoclonal antibody. TG …
Before the market opened today, MLV analyst Arlinda Lee reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $22 price target, which …
In a research report released this morning, MLV analyst Arlinda Lee maintained a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a price target …
In a research report sent to investors, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a price …
In a research report published Wednesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $22 price …
In a research report sent to investors yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a …
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $22 price target, …
In a research report sent to investors today, Roth Capital analyst Joseph Pantginis maintained a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $25 price …
Brean Capital analyst Jonathan Aschoff maintained a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $22 price target, following the company’s third-quarter financial results and …
In a research note issued yesterday, H.C.